Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Feldman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer|May 31, 2014
Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neckRon R Allison, Aaron A Ambrad, Youssef Arshoun, et al.
Cancer Research|March 27, 2024
NPEPPS Is a Druggable Driver of Platinum ResistanceRobert T Jones, Mathijs Scholtes, Andrew Goodspeed, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Microbiome-based risk prediction in incident heart failure: a community challengePande Putu Erawijantari, Ece Kartal, José Liñares-Blanco, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|October 17, 2018
2018 American Society of Consultant Pharmacists Annual Meeting & ExhibitionMary Bridgeman, Donna Prete, Nicole Rolston, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer|May 31, 2014
Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neckRon R Allison, Aaron A Ambrad, Youssef Arshoun, et al.
Cancer Research|March 27, 2024
NPEPPS Is a Druggable Driver of Platinum ResistanceRobert T Jones, Mathijs Scholtes, Andrew Goodspeed, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Microbiome-based risk prediction in incident heart failure: a community challengePande Putu Erawijantari, Ece Kartal, José Liñares-Blanco, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|October 17, 2018
2018 American Society of Consultant Pharmacists Annual Meeting & ExhibitionMary Bridgeman, Donna Prete, Nicole Rolston, et al.
Pageof 2